Jazz Pharmaceuticals JAZZ Financing Cash Flow
Financing Cash Flow at other companies
Other financials
Where this comes from
Reported directly by Jazz Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInFinancingActivities.
The official record: Jazz Pharmaceuticals’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Jazz Pharmaceuticals's financing cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Jazz Pharmaceuticals's financing cash flow?
- Jazz Pharmaceuticals (JAZZ) reported financing cash flow of -$78.5M in Q1 2026.
- How has Jazz Pharmaceuticals's financing cash flow changed year-over-year?
- Jazz Pharmaceuticals's financing cash flow increased by 90.4% year-over-year, from -$813.5M to -$78.5M.
- What does financing cash flow mean?
- The net result of all cash movements between the company and its investors or lenders.
- How do you interpret financing cash flow?
- Positive values suggest capital raising or borrowing; negative values suggest debt repayment, share buybacks, or dividend payments.
- How does financing cash flow compare across companies?
- Highly variable based on the company's lifecycle stage and capital structure strategy.